Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
47.4 (1y: +42%)
Market Cap 77.2 B P/E(ttm) 148.10
Enterprise Value 82.56 B P/B 5.70
BMY- NYSE (USA)
Bristol-Myers Squibb Company
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$47.40
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M77,200Revenue $M16,201Net Margin (%)11.1Z-Score4.4
Enterprise Value $M81,765EPS $0.9Operating Margin %12.8F-Score5
P/E(ttm))148Cash Flow Per Share $2.8Pre-tax Margin (%)13.3Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %1.6Quick Ratio1.8Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %-3.4Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %-42.4ROA % (ttm)5.5Higher Current Ratio y-yN
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)14.4Less Shares Outstanding y-yN
Payout Ratio %170Shares Outstanding M1,637ROI % (ttm)16.3Gross Margin Increase y-yY

Gurus Latest Trades with BMY

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
Total Records: 77   Page:1 2 3 4 Next Page
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
BMYVanguard Health Care Fund 2013-03-31 Add0.96%$32.59 - $41.19
($36.62)		 $ 47.429%Add 49.53%17,948,561
BMYRay Dalio 2013-03-31 Add0.05%$32.59 - $41.19
($36.62)		 $ 47.429%Add 267.87%181,140
BMYJohn Hussman 2013-03-31 Sold Out -0.64%$32.59 - $41.19
($36.62)		 $ 47.429%Sold Out0
BMYJames Barrow 2013-03-31 Sold Out -0.05%$32.59 - $41.19
($36.62)		 $ 47.429%Sold Out0
BMYJohn Hussman 2012-12-31 Reduce-0.2%$30.81 - $34.38
($32.89)		 $ 47.444%Reduce -25%750,000
BMYJames Barrow 2012-12-31 Reduce-0.02%$30.81 - $34.38
($32.89)		 $ 47.444%Reduce -22.36%795,409
BMYRay Dalio 2012-12-31 Reduce-0.01%$30.81 - $34.38
($32.89)		 $ 47.444%Reduce -21.64%49,240
BMYRay Dalio 2012-09-30 Buy 0.03%$31.53 - $36.14
($33.81)		 $ 47.440%New holding, 62840 sh.62,840
BMYPrem Watsa 2012-06-30 Reduce$32.37 - $35.49
($33.66)		 $ 47.441%Reduce -30%7,000
BMYRichard Perry 2012-06-30 Sold Out -0.04%$32.37 - $35.49
($33.66)		 $ 47.441%Sold Out0
BMYMario Gabelli 2012-03-31 Add0.06%$31.85 - $35.01
($30.47)		 $ 47.456%Add 33.64%928,152
BMYRichard Perry 2012-03-31 Buy 0.04%$31.85 - $35.01
($30.47)		 $ 47.456%New holding, 22200 sh.22,200
BMYJohn Hussman 2011-12-31 Reduce-0.5%$30.15 - $35.29
($32.54)		 $ 47.446%Reduce -50%1,000,000
BMYVanguard Health Care Fund 2011-09-30 Add0.17%$26.38 - $31.49
($29.18)		 $ 47.462%Add 8.84%12,003,061
BMYJames Barrow 2011-09-30 Reduce-0.65%$26.38 - $31.49
($29.18)		 $ 47.462%Reduce -88.35%1,463,209
BMYJoel Greenblatt 2011-09-30 Sold Out -0.041%$26.38 - $31.49
($29.18)		 $ 47.462%Sold Out0
BMYRay Dalio 2011-09-30 Sold Out -0.04%$26.38 - $31.49
($29.09)		 $ 47.463%Sold Out0
BMYVanguard Health Care Fund 2011-06-30 Add0.24%$26.46 - $29.33
($28.07)		 $ 47.469%Add 17.59%11,028,361
BMYJohn Hussman 2011-06-30 Add0.23%$26.46 - $29.33
($28.07)		 $ 47.469%Add 33.33%2,000,000
BMYGeorge Soros 2011-06-30 Sold Out $26.46 - $29.33
($28.07)		 $ 47.469%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 77   Page:1 2 3 4 Next Page

BMY is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BMY Ray Dalio 2013-03-31181,1400.010.07+267.87%
BMY Vanguard Health Care Fund 2013-03-3117,948,5611.12.9+49.53%
BMY Mario Gabelli 2013-03-31951,9950.060.25+5.77%
BMY Prem Watsa 2013-03-317,00000.01
BMY Jean-Marie Eveillard 2013-03-3116,52000
BMY Dodge & Cox 2013-03-3180,12100
BMY James Barrow 2013-03-31000Sold Out
BMY John Hussman 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caforio GiovanniPres., US Pharmaceuticals 2013-05-23Sell26,647$46.291.53view
Cazala Beatrice JEVP Commercial Operations 2013-05-23Sell96,000$46.990.02view
CORNELIUS JAMES MDirector 2013-05-17Sell225,996$42.999.33view
CORNELIUS JAMES MDirector 2013-05-08Sell20,000$39.8517.94view
DANIELS BRIANSVP Global Dev & Med Affairs 2013-05-08Sell15,000$39.9317.71view
CORNELIUS JAMES MDirector 2013-05-02Sell20,000$39.7618.21view
SIGAL ELLIOTEVP, CSO & President R&D 2013-04-30Sell506,507$39.7118.36view
CORNELIUS JAMES MDirector 2013-04-26Sell20,000$40.2316.83view
CORNELIUS JAMES MDirector 2013-04-17Sell20,000$40.7915.22view
CORNELIUS JAMES MDirector 2013-04-11Sell20,000$41.1514.22view

Press Releases about BMY:

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Johnson & Johnson (JNJ) Dividend Stock Analysis May 23 2013 
Characteristics of Great Dividend Growth Stocks Apr 24 2013 
20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 22 2013 
10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013 
Abbott Laboratories (ABT) Dividend Stock Analysis Dec 27 2012 
Stocks to Buy on Dips: Teva Dec 27 2012 
Abbott Laboratories: Quality Dividend Aristocrat for Long Term Dividends Dec 21 2012 
This Dividend Stock Traces Its Origin Back to Oldsmobile Dec 10 2012 
The Best Stocks with Dividend Growth from Last Week Dec 09 2012 

More From Our Partners
Gilead's Sofosbuvir under European Review - Analyst Blog May 22 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK